SCHEMBL798146

SCHEMBL798146

Cc1ccncc1N1CCc2cc(O)c(Cl)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 3/20 0.42
DRD2 P14416 1/20 0.42
DRD5 P21918 1/20 0.42
DRD3 P35462 1/20 0.42
HTR2A P28223 4/20 0.40
HTR2C P28335 4/20 0.40
PDGFRB P09619 1/20 0.39
KDR P35968 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
CYP11B2 P19099 3/20 0.37
CYP11B1 P15538 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HTR2B P41595 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL793474 0.85 CYP11B2 (0.41) HTR2AHTR2CPDGFRBKDRCYP11B2
SCHEMBL798654 0.84 PDGFRB (0.43) DRD1DRD2DRD5DRD3PDGFRB
SCHEMBL793623 0.83 MAPT (0.52) HTR2CSMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL793143 0.76 GRIN2D (0.42) PDGFRBKDRCYP11B2CYP11B1ALDH1A1
SCHEMBL793750 0.75 CYP11B2 (0.46) HTR2AHTR2CHSP90AA1HSP90AB1CYP11B2
SCHEMBL11567042 0.75 DRD1 (0.56) DRD1DRD2DRD5DRD3SMN1; SMN2
SCHEMBL798533 0.74 TIPARP (0.46) DRD1DRD2DRD5DRD3PDGFRB
SCHEMBL794272 0.73 PHGDH (0.43) HTR2AHTR2CPDGFRBKDR
SCHEMBL793875 0.73 TRPV3 (0.41) HTR2AHTR2CPDGFRBKDR
SCHEMBL27919644 0.73 DRD1 (0.38) DRD1DRD2DRD5HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed